Epidemiology and Outcome of Patients With Burns Treated With Cerium Nitrate Silversulfadiazine.

J Burn Care Res

From the *Burn Centre, Martini Hospital, Groningen, The Netherlands; †Association of Dutch Burn Centres, Burn Centre, Martini Hospital, Groningen, The Netherlands; and ‡Association of Dutch Burn Centres, Burn Centre, Maasstad Hospital, Rotterdam, The Netherlands.

Published: February 2018

In this study, the outcome of treatment with Flammacerium in burn patients is studied. The retrospective study involved patients with acute burns admitted to the Burn Centre of Martini Hospital, Groningen, The Netherlands, between 2009 and 2014. The outcome parameters were mortality, complications (noninfectious and infectious), need of surgery, and length of stay. The group of patients consisted of 853 patients, of which 554 were male (64.9%). There were 23 patients with a total burn size of 40% TBSA or more (2.7%). In total, 13 of the 853 patients (1.5%) died, and none of them were children (<16 years). The overall mortality in the group of patient with burns >40% TBSA was 30.4%. In the elderly group (>70 years), the mortality rate was 6.3%. Treatment with Flammacerium is applicable in all thermal burn patients. Especially children, elderly patients, and patients with severe burns can benefit from a more conservative treatment with Flammacerium whereby the first operation can be postponed until the patient is stabilized and in which the wounds can be covered directly with skin transplants.

Download full-text PDF

Source
http://dx.doi.org/10.1097/BCR.0000000000000448DOI Listing

Publication Analysis

Top Keywords

treatment flammacerium
12
patients
10
burn patients
8
853 patients
8
40% tbsa
8
epidemiology outcome
4
outcome patients
4
patients burns
4
burns treated
4
treated cerium
4

Similar Publications

: Due to rising antibiotic-resistant microorganisms, there is a pressing need to screen approved drugs for repurposing and to develop new antibiotics for controlling infections. Current in vitro and ex vivo models have mostly been unsuccessful in establishing in vivo relevance. In this study, we developed a stringent ex vivo-burned porcine skin model with high in vivo relevance to screen topical antimicrobials.

View Article and Find Full Text PDF

Background: Burn injury is a major global health crisis. Topical antimicrobials such as silver sulfadiazine (SSD) are commonly used for superficial burn wounds. SSD has a broad-spectrum antimicrobial activity and also anti-inflammatory property, but also suffers from some limitations.

View Article and Find Full Text PDF

The Use of Cerium Compounds as Antimicrobials for Biomedical Applications.

Molecules

April 2022

Mechanisms of Health & Disease, School of Clinical Dentistry, The University of Sheffield, Sheffield S10 2TA, UK.

Cerium and its derivatives have been used as remedies for wounds since the early 20th century. Cerium nitrate has attracted most attention in the treatment of deep burns, followed later by reports of its antimicrobial properties. Its ability to mimic and replace calcium is presumed to be a major mechanism of its beneficial action.

View Article and Find Full Text PDF

Flammacerium is a topical treatment composed of silver sulfadiazine and cerium nitrate initially used in burns. The objective was to assess the effectiveness of silver sulfadiazine and cerium nitrate on ischemic necrosis wounds of the lower limb as an alternative to amputation for a period of 12 weeks. Patients were prospectively randomized to receive silver sulfadiazine and cerium nitrate or standard care.

View Article and Find Full Text PDF

Aim: The aim of this study was to compare the clinical outcomes of different treatment strategies for children with partial-thickness scalds at two burn centers. At the first burn center, these burns were treated with a hydrofiber dressing (Aquacel, Convatec, Inc., Princeton, NJ, USA) or silver sulfadiazine (SSD, Flammazine, Sinclair IS Pharma, London, UK Pharmaceuticals), while at the second burn center, cerium nitrate-silver sulfadiazine (CN-SSD, Flammacerium, Sinclair IS Pharma, London, UK Pharmaceuticals) was used.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!